购物车
全部删除
您的购物车当前为空
D3S-001 作为一种口服有效的KRAS抑制剂,其对 KRASG12C突变体 H358 和 MIA-PA-CA-2 的细胞增殖具有显著抑制作用,其IC50值分别为0.6 和 0.44 nM.在多种物种的肝细胞、肝微粒体、血浆和全血中,D3S-001均显示出优良的代谢稳定性.此外,D3S-001在小鼠体内展示了良好的药代动力学属性和抗肿瘤活性.

D3S-001 作为一种口服有效的KRAS抑制剂,其对 KRASG12C突变体 H358 和 MIA-PA-CA-2 的细胞增殖具有显著抑制作用,其IC50值分别为0.6 和 0.44 nM.在多种物种的肝细胞、肝微粒体、血浆和全血中,D3S-001均显示出优良的代谢稳定性.此外,D3S-001在小鼠体内展示了良好的药代动力学属性和抗肿瘤活性.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
D3S-001 相关产品
| 产品描述 | D3S-001 is an orally effective KRAS inhibitor. It suppresses the proliferation of the KRASG12C mutants H358 and MIA-PA-CA-2 with IC50 values of 0.6 and 0.44 nM, respectively. D3S-001 exhibits good metabolic stability across multiple species in hepatocytes, liver microsomes, plasma, and whole blood. Additionally, it demonstrates favorable pharmacokinetic properties and antitumor activity in mice. |
| 分子量 | 679.66 |
| 分子式 | C32H35F6N7O3 |
| CAS No. | 2914919-85-8 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容